J Pediatr Intensive Care 2024; 13(04): 344-351
DOI: 10.1055/s-0042-1742674
Original Article

Safety and Effectiveness of Prolonged Magnesium Sulfate (MgSO4) Infusion for Asthma Exacerbation in Children

1   Section of Pediatric Intensive Care, Child Health Department, The Royal Hospital, Muscat, Oman
,
Atheer Ahmed Alkhan
2   Child Health Department, The Royal Hospital, Muscat, Oman
,
Muzna Yahya Al-Farsi
2   Child Health Department, The Royal Hospital, Muscat, Oman
,
Ahmed Mohammed Al Kamzari
2   Child Health Department, The Royal Hospital, Muscat, Oman
› Author Affiliations
Preview

Abstract

The objective of this study was to assess the safety and describe treatment details of prolonged magnesium sulfate (MgSO4) infusion for children with asthma exacerbation. A retrospective cross-sectional study included children under 13 years of age who were admitted with asthma exacerbation and received at least 24 hours of MgSO4 infusion. One hundred children were included. No patients developed serious adverse events. The mean infusion duration was 74.2 hours. Eighty-nine percent recovered with no other bronchodilator infusions, and 94% did not require respiratory support escalation. Prolonged MgSO4 infusion is safe at a maximum dose of 30 mg/kg/h and may be beneficial for children with asthma exacerbation.



Publication History

Received: 06 July 2021

Accepted: 30 December 2021

Article published online:
21 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany